EPISODE · Sep 21, 2020 · 30 MIN
Sally Mossman, GSK (EP.65)
Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.
NOW PLAYING
Sally Mossman, GSK (EP.65)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m